Dr. Sidhartha Singh Tulachan, MD

Dr. Tulachan practices at BHS Physicians Network, Inc in El Paso, Texas.

Dr. Tulachan's NPI, 1891003620, was assigned on September 14, 2010. Dr. Tulachan graduated from Tribhuvan University Inst of Medicine in 1998. Dr. Tulachan holds Texas license Q8375.

Dr. Tulachan's primary practice is BHS Physicians Network, Inc, at 1250 E Cliff Dr, El Paso, TX 79902 in El Paso County. The practice phone is (207) 323-7336.

Dr. Tulachan's primary practice is BHS Physicians Network, Inc in El Paso, Texas. Dr. Tulachan is also affiliated with The Hospitals of Providence - Sierra Campus. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Dr. Tulachan to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tulachan practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tulachan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tulachan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Tulachan's licenses on file in 4 states: Texas, Indiana, Georgia and Ohio.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy and fatty liver among the conditions Dr. Tulachan treats.

CMS data shows 340 Medicare services from Dr. Tulachan across 8 procedure codes in 2024, for 154 Medicare patients. Medicare paid $29,120 for them.

CMS counts 154 Medicare patients who saw Dr. Tulachan in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tulachan's median patient age at 68, with 60% women.

In 2024, Dr. Tulachan wrote 1,609 Medicare Part D claims for 458 patients. 78% of them were for generic drugs. CMS names the drug for 1,379 of them, across 23 drugs with 11 or more claims each, at $218,071 in total drug cost. In 2023, CMS named 1,505 claims across 24 drugs.

Dr. Tulachan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 65 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tulachan, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 31 papers to Dr. Tulachan, published from 2005 to 2015. 2013 was the busiest year, with 4. The most frequent topics are Signal Transduction, Immunohistochemistry and Cell Differentiation. Dr. Tulachan has published most often in Clin Cancer Res. Dr. Tulachan's most frequent co-authors are George K. Gittes, MD, John C. Wiersch, MD and Sohail R. Shah, MD.

CMS Open Payments shows 101 general payments to Dr. Tulachan from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,177.

Dr. Tulachan graduated from Tribhuvan University Inst of Medicine in 1998.

Dr. Tulachan is in network with 24 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.